These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6739517)

  • 1. Chronic scopolamine treatment and brain cholinergic function.
    Marks MJ; O'Connor MF; Artman LD; Burch JB; Collins AC
    Pharmacol Biochem Behav; 1984 May; 20(5):771-7. PubMed ID: 6739517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic adaptations to chronic oxotremorine infusion.
    Marks MJ; Artman LD; Patinkin DM; Collins AC
    J Pharmacol Exp Ther; 1981 Aug; 218(2):337-43. PubMed ID: 7252834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic influences on tolerance development with chronic oxotremorine infusion.
    Marks MJ; Romm E; Collins AC
    Pharmacol Biochem Behav; 1987 Aug; 27(4):723-32. PubMed ID: 3659096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo modulation of the number of muscarinic receptors in rat brain by cholinergic ligands.
    Ben-Barak J; Gazit H; Silman I; Dudai Y
    Eur J Pharmacol; 1981 Aug; 74(1):73-81. PubMed ID: 7318895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo modulation of cholinergic muscarinic receptors in rat lymphocytes and brain by cholinergic agents.
    Costa LG; Kaylor G; Murphy SD
    Int J Immunopharmacol; 1990; 12(1):67-75. PubMed ID: 2303319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-tolerance between muscarinic agonists: role of muscarinic receptors.
    Collins AC; Smolen TN; Smolen A; Medhurst LJ
    Pharmacol Biochem Behav; 1987 Jan; 26(1):173-82. PubMed ID: 3562489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential alterations of cholinergic muscarinic receptors during chronic and acute tolerance to organophosphorus insecticides.
    Costa LG; Schwab BW; Murphy SD
    Biochem Pharmacol; 1982 Nov; 31(21):3407-13. PubMed ID: 7150362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the interaction of drugs with the cholinergic nervous system--IV. Tolerance to oxotremorine in mice: in vivo and in vitro studies.
    Maayani S; Egozi Y; Pinchasi I; Sokolovsky M
    Biochem Pharmacol; 1977 Sep; 26(18):1681-7. PubMed ID: 901587
    [No Abstract]   [Full Text] [Related]  

  • 9. The pharmacological assessment of RS 86 (2-ethyl-8-methyl-2,8-diazaspiro-[4,5]-decan-1,3-dion hydrobromide). A potent, specific muscarinic acetylcholine receptor agonist.
    Palacios JM; Bolliger G; Closse A; Enz A; Gmelin G; Malanowski J
    Eur J Pharmacol; 1986 Jun; 125(1):45-62. PubMed ID: 3732391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of sensitivity to oxotremorine and muscarinic receptors in LS and SS mice.
    Collins AC; Campbell SM; Romm E; Marks MJ
    Alcohol Clin Exp Res; 1990 Aug; 14(4):605-15. PubMed ID: 2221290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic drug effects and brain muscarinic receptor binding in aged rats.
    Pedigo NW; Minor LD; Krumrei TN
    Neurobiol Aging; 1984; 5(3):227-33. PubMed ID: 6514108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chronic lithium on cholinergically mediated responses and [3H]QNB binding in rat brain.
    Lerer B; Stanley M
    Brain Res; 1985 Oct; 344(2):211-9. PubMed ID: 4041871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of decreased numbers of muscarinic receptors from tolerance to DFP.
    Smolen TN; Smolen A; Collins AC
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1293-301. PubMed ID: 3809233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contraction and [3H]QNB binding in collagenase isolated fundic smooth muscle cells.
    Seidel ER; Johnson LR
    Am J Physiol; 1983 Aug; 245(2):G270-6. PubMed ID: 6881350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of tolerance development after chronic oxotremorine treatment.
    Marks MJ; Artman LD; Collins AC
    Pharmacol Biochem Behav; 1983 Jul; 19(1):103-13. PubMed ID: 6622504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biochemical studies of oxiracetam (CT-848) on cholinergic neurons].
    Mochizuki D; Sugiyama S; Shinoda Y
    Nihon Yakurigaku Zasshi; 1992 Jan; 99(1):27-35. PubMed ID: 1559636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically-determined responses of central cholinergic markers: the effects of ethanol on inbred strains of mice.
    Hashemzadeh-Gargari H; Mandel P
    Neurotoxicology; 1989; 10(3):555-68. PubMed ID: 2626217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BM-5, a centrally active partial muscarinic agonist with low tremorogenic activity. In vivo and in vitro studies.
    Engström C; Undén A; Ladinsky H; Consolo S; Bartfai T
    Psychopharmacology (Berl); 1987; 91(2):161-7. PubMed ID: 3107028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic/serotonergic interactions in hypothermia: implications for rat models of depression.
    Overstreet DH; Daws LC; Schiller GD; Orbach J; Janowsky DS
    Pharmacol Biochem Behav; 1998 Apr; 59(4):777-85. PubMed ID: 9586831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.